Status:

COMPLETED

Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

High Risk for Postoperative Cardiovascular Events

Eligibility:

All Genders

50+ years

Brief Summary

The purpose of this study is to look at a new method for finding out if patients have a risk of heart complications from surgery. At the present, to find out if patients have a risk of heart complicat...

Eligibility Criteria

Inclusion

  • Age 50 or older
  • Undergoing High Risk Cancer Surgery (Patient must be undergoing one of the following procedures NOTE: All open or robotic forms of the following procedures meet the eligibility criteria. GMT/ Hepatobiliary
  • Pancreatic Resection
  • Retroperitoneal Sarcomas
  • Shoulder (Forequarter) Amputation
  • Esophagectomy, Esophagogastrectomy
  • Pheochromocytoma
  • Liver Resection (with or without Bile Duct Resection) Orthopedics
  • Spine Resections (with or without Spinal Fusion)
  • Metastatic Disease Requiring Total Hip Replacement
  • Total Shoulder Replacement / Forequarter Amputation
  • Hemipelvectomy
  • Sacrectomy Thoracic
  • Extrapleural Pneumonectomy
  • Pleurectomy and Decortication
  • Pneumonectomy
  • Esophagogastrectomy
  • Mediastinal Tumor Resection
  • Pancoast Tumor
  • Completion Pneumonectomy
  • Lobectomy (post-induction chemotherapy; or severe COPD)
  • Segmentectomy Colorectal/ GYN
  • Colon Resection with possible Sacrectomy
  • Pelvic Exenteration
  • Advanced ovarian cancer resection with or without liver resection Urology
  • Radical Cystectomy
  • Open Radical Prostatectomy
  • Nephrectomy with Vena Caval Resection Head \& Neck
  • Thyroid Resection with Mediastinal involvement
  • Major head and neck cancer resection with Free Flap reconstruction Other
  • Unclassified Major Surgery at the Discretion of the PI
  • Postoperative stay likely to be 2 or more days
  • Patients willing to tolerate inflation of a blood pressure cuff for 5 minutes
  • Patients willing to cut long nails in order to wear finger probe.
  • Patients with one or more of the following RCRI risk factors:
  • History of ischemic heart disease (any)
  • History of myocardial infarction
  • History of positive exercise test
  • Current complaint of chest pain considered secondary to myocardial ischemia
  • Use of nitrate therapy
  • ECG with pathological Q waves
  • History of congestive heart failure (any)
  • History of congestive heart failure
  • Pulmonary edema
  • Paroxysmal nocturnal dyspnea
  • Bilateral rales or S3 gallop
  • Chest radiograph showing pulmonary vascular redistribution
  • History of cerebrovascular disease (any)
  • History of transient ischemic attack (TIA) or stroke
  • Preoperative treatment with insulin
  • Preoperative serum creatinine \> 2.0 mg/dL
  • Evidence of peripheral vascular disease other than cerebral vascular disease (Although peripheral vascular disease is not strictly a RCRI risk factor, Fleisher indicates: "It would not be inappropriate to assume that any atherosclerotic class of disease is equivalent to ischemic heart disease for risk purposes."

Exclusion

  • Medical conditions precluding use of arm blood pressure measurements such as prior lymphadenectomy, vascular shunts for dialysis or upper extremity occlusive vascular disease
  • Patients undergoing emergency surgery
  • Any of the following active conditions
  • Unstable coronary syndromes
  • Uncompensated heart failure; worsening or new onset CHF
  • Significant arrhythmias
  • Atrial fibrillation, presently
  • High grade AV block
  • Symptomatic ventricular arrhythmias or new ventricular arrhythmias
  • Supraventricular arrhythmias with poor rate control
  • Symptomatic bradycardia
  • Severe valvular disease
  • Severe aortic stenosis (mean transvalvular gradient \>40mmHg)
  • Symptomatic mitral stenosis
  • Any other condition that at the judgment of the investigator might require additional evaluation and treatment before surgery.

Key Trial Info

Start Date :

December 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 11 2018

Estimated Enrollment :

67 Patients enrolled

Trial Details

Trial ID

NCT01262222

Start Date

December 1 2010

End Date

July 11 2018

Last Update

July 13 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10065